A.I. Flow Inc. is a startup founded by a PhD in MEMS from Seoul National University, developing a patch-type insulin pump and next-generation glucose management platform based on proprietary actuator design technology. By avoiding existing monopoly patents, the company aims to deliver greater insulin capacity, faster bolus injection, and reduced manufacturing costs through a reusable module structure, securing strong competitiveness. Once commercialized, A.I. Flow has the potential to expand beyond type 1 diabetes to also address the type 2 diabetes market.
